Stabilizing the Antimalarial Drug Supply: Semisynthetic Artemisinin Could Meet up to One-Third of Global Need

Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. This fact sheet describes the cross-sector partnership PATH formed to develop a new way to produce high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply.

Publication date: July 2014

Stabilizing the Antimalarial Drug Supply

430.2 KB PDF
View Resource